New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
07:07 EDTCBLICleveland BioLabs subsidiary signs contract for about $4.6M with Russia
Cleveland BioLabs and Panacela Labs announced award of a contract valued at 146 million rubles, or approximately $4.6M with the Ministry of Industry and Trade of the Russian Federation for development of Xenomycins, a family of compounds in development as anti-infective agents. The contract, issued under the Russian Federation's "Pharma 2020" development initiative, provides matching funding over a period of approximately three years, which will be used to support preclinical and clinical studies.
News For CBLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
07:44 EDTCBLICleveland BioLabs announces growth of Curaxin CBL0137 patent portfolio
Subscribe for More Information
February 27, 2015
18:02 EDTCBLICleveland BioLabs files to sell 2.07M shares of common stock for holders
Subscribe for More Information
February 24, 2015
07:39 EDTCBLICleveland BioLabs reports Q4 EPS ex-gain ($1.02) vs. (16c) last year
Subscribe for More Information
February 18, 2015
07:39 EDTCBLICleveland BioLabs announces receipt of letter from NASDAQ confirming compliance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use